Biomedical Science and Research Journals | Endothelial Progenitor Cells: Characterization and Role in Cerebral Arteriovenous Malformation
Endothelial Progenitor Cells: Characterization and Role in Cerebral Arteriovenous Malformation
Abstract
Background: The angiogenesis in Cerebral Arteriovenous
malformations (cAVMs) may occur through activation of chemokines
[stromal-cell
derived factor-1 (SDF-1)], which ultimately recruit endothelial
progenitor cells (EPCs) for aberrant neovascularization. Thus, we
determined the
role of EPCs in the vasculogenesis of cAVMs.
Methods: Literature search was made through electronic
database on “PubMed”, “EMBASE”, “Google Scholar”, and “Science Direct”
from 1990-
2019 using MeSH headings of “Endothelial Progenitor Cells”,
“Arteriovenous Malformation”, and “Stromal-cell derived factor-1
(SDF-1)” using
Boolean operator “and”/”or”. The inclusion criterion included human
experimental studies on EPCs in the cAVMs.
Results: Histo morphological characteristics of
vasculogenesis, both quantitatively and qualitatively, are pivotal in
determining the prognosis of
patients with AVMs. cAVMs patients have higher expression of markers of
EPCs precursors, which is characterized by stem cell (CD133),
endothelial
(VEGF-2, CD31, and/or VE-cadherin), and hematopoietic cell markers
(CD31). The SDF-1 was co-expressed with CD31+, predominantly on the
endothelium of the vessel wall, and recruit ECPs from the peripheral
cells to the target tissues thus leads to active remodeling and
angiogenesis. A
positive correlation exists between the VEGF- A (r=0.53) or HIF-1 α
(r=0.43) and SDF-1 α.
Conclusion: The EPCs plays an important role in the vasculogenesis of cAVMs lesions through activation by SDF-1/CXCR4 pathway. Therefore,
further experimental studies are needed to formulate a therapy targeting these EPCs in the management of patients with cAVMs.
Keywords: Arteriovenous Malformations; Endothelial cell; Precursor cells
Introduction
Depression, Anxiety, Stress and Fear
Cerebral Arteriovenous malformations (cAVMs) are characterized by “nidus”, which is a group of abnormally dilated blood vessels, due to aberrant angiogenesis and vascular re modeling [1]. Histopathological and molecular analysis of these CAVMs revealed higher level of angiogenic factors and vascular cytokines of the cAVMs [2,3]. Concentrated effects of angiogenic and inflammatory factors, which include angiopoietin-2, matrix metalloproteinase (MMP)-9, vascular endothelial growth factors (VEGF), and IL-6 contribute towards maintaining the angiogenic phenotype of the cAVMs [4,5].Endothelial progenitor cells (EPCs), derived from bone marrow, plays an indispensable role in initiating and promoting abnormal tumor vasculogenesis by either secreting paracrine factors or by incorporating directly into the vasculature [6,7]. Stromal cell derived factor-1 (SDF-1) is a chemokine that is thought to be associ ated with recruitment of EPCs [8]. Therefore, SDF-1 could induce differentiation and proliferation of endothelial cells along with its synergistic effect on VEGF on inducing neo-angiogenesis [9]. There exist a few literatures investigating the role of EPCs in the cAVMs, therefore, we did a systematic review to understand the molecular impact of EPCs in influencing the disease progression and vascular remodeling [10].
Methods
A systematic search of electronic databases which included “PubMed”, “EMBASE”, “Google Scholar”, and “Science Direct” from January 1st, 1990 to May 31st, 2019. Different MeSH terms were searched which included, “Endothelial Progenitor Cells (EPCs)”, “Arteriovenous Malformations”, and “Stromal-cell derived factor-1”. The studies investigating the role of EPCs in cAVMs in humans were included. Experimental studies on rats and AVM other than brain were excluded for our review. The data was extracted by one author (NF, and no restriction in language was applied for our search. Statistical analysis was not performed due to a few numbers of studies.Results
Vasculogenesis
Immunohistochemical analysis revealed that stem cell marker CD133+ co-expressed with KDR was positive in the brain AVMs nidus specifically in the vessel wall. This co-expression revealed that EPCs might be associated with remodeling of the vascular wall in AVMs as indicated in (Table 1).
Table 1:Different Immunohistochemical markers identified in patients with cerebral AVMs.
Furthermore, double immunohistochemistry revealed that
SDF-1 positive signals were expressed strongly in smooth muscle of
the artery and vessel endothelial cells. SDF-1 is the cellular source
of CD31, α-SMA, and CD-68. CD68+ signals were present mainly in
the vessel wall and in the adjacent parenchymal tissue of the AVM
nidus. There was a positive correlation between SDF1/CXCR1-pathway
and VEGF- α or HIF-1 α (p<0.05) [11].Neovascularization
CD31+, CD34+, CD133+ have been associated with increased angiogenesis depending upon the increased stage of AVM (p=0.004) [12]. They are expressed in the endothelium of the vessel wall.
Discussion
Cerebral arteriovenous malformations (cAVMs) are abnormal,
tortuous, dilated and tangled group of blood vessels connecting
artery to vein without a capillary bed [13]. Previous studies have
revealed that there exists an active remodeling process and angiogenesis
in cAVMs, leading to progressive change in the size of these
malformations [14]. Therefore, the literature exists to identify the
role of EPCs in active vascular remodeling of these cerebral AVMs
[13-16].
EPCs are precursors of bone-marrow derived cells with the
potential to differentiate into mature endothelial cells [17]. These
cells have positive marker for stem cell CD133 [18], the hematopoietic
marker CD34 [19], as well as endothelial cell markers [20]:
VEGF-2, CD31, and/or VE-cadherin. The exact phenotype of EPCs
is still unknown but the combination of endothelial and hematopoietic
lineage markers has been characterized to identify the EPCs
[17-20]. Physiological and pathological conditions which include,
angiogenic stimulation, ischemia, trauma and inflammation leads
to endogenous mobilization of EPCs from bone marrow to peripheral
blood [21]. EPCs migrate accelerate neovascularization by migrating
and localizing to the sites of active remodeling and vasculogenesis
[21,22]. Elevated level of EPCs have been found in multiple
cancers which include lung cancer, breast cancer, multiple myeloma,
and early stages of infantile hemangioma [22,23]. In contrast,
patients with diabetes mellitus and stroke have decreased level of
EPCs compared with the control subjects [23,24].
In addition, SDF-1 is a specific mediator of EPCs mobilization
and is a chemokine that helps in migrating the EPCs from the peripheral
blood to the target tissue [25]. Double-fluorescent study
revealed that expression of SDF-1 is upregulated in the nidus of
brain AVMs, which is strongly associated with vasculogenesis and
remodeling [26]. AVMs are characterized by high-flow shunting,
therefore, expression of these EPCs will lead to more efficient
adaptive process in terms of increased number of endothelial cells
mitigating the effect of high flow blood and decreasing the risk of
rupture of the nidus [1,2,17].
In summary, our systematic review highlighted the fact that in
cerebral AVMs the activation of endothelial and stem cell markers
leads to recruitment of EPCs that leads to abnormal vascular formation.
However, further studies are needed to identify targeted
therapy for these precursor cells in the management of patients
with AVMs
To view fulltext of article:https://biomedgrid.com/fulltext/volume3/endothelial-progenitor-cells-characterization-and-role-in-cerebral-arteriovenous-malformation.000697.php
Comments
Post a Comment